Concepedia

Nate Taneja

NT

Statistics

Publications

8

Citations

1.6K

H-Index

8

Active since

2012

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

Vanderbilt University

University of California, Los Angeles

Nate Taneja is an author at Alnylam Pharmaceuticals (United States) specializing in molecular biology, life sciences, and rna interference.

Publications per year

2012–2023

8

Publications

8

Multivalent <i>N</i>-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing

Jayaprakash K. Nair, Jennifer L. S. Willoughby, Amy Chan et al. · Journal of the American Chemical Society · 2014 · 1.1K citations

, , +17

Hepatocyte‐Specific Delivery of siRNAs Conjugated to Novel Non‐nucleosidic Trivalent <i>N</i>‐Acetylgalactosamine Elicits Robust Gene Silencing in Vivo

Kallanthottathil G. Rajeev, Jayaprakash K. Nair, Muthusamy Jayaraman et al. · ChemBioChem · 2015 · 184 citations

, , +17

Chirality matters: stereo-defined phosphorothioate linkages at the termini of small interfering RNAs improve pharmacology <i>in vivo</i>

Hartmut Jahns, Nate Taneja, Jennifer L. S. Willoughby et al. · Nucleic Acids Research · 2021 · 86 citations · Full text

, , +17

4′-<i>C</i>-Methoxy-2′-deoxy-2′-fluoro Modified Ribonucleotides Improve Metabolic Stability and Elicit Efficient RNAi-Mediated Gene Silencing

Elise Malek-Adamian, Dale C. Guenther, Shigeo Matsuda et al. · Journal of the American Chemical Society · 2017 · 68 citations

, , +17

Structural basis for the synergy of 4′- and 2′-modifications on siRNA nuclease resistance, thermal stability and RNAi activity

Joel M. Harp, Dale C. Guenther, Anna Bisbe et al. · Nucleic Acids Research · 2018 · 47 citations · Full text

, , +17

1–5 of 8